Frontier Capital Management CO LLC Nektar Therapeutics Transaction History

Frontier Capital Management CO LLC

$9.96 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$4.16 - $13.72 $461,011 - $1.52 Million	-110,820 Closed	0 $0
Q4 2021 Jan 19, 2022	BUY	$10.83 - $18.41 $184,326 - $313,338	17,020 Added 18.14%	110,820 $1.5 Million
Q3 2021 Oct 19, 2021	SELL	$13.07 - $18.84 $301,537 - $434,657	-23,071 Reduced 19.74%	93,800 $1.69 Million
Q2 2021 Aug 09, 2021	SELL	$16.52 - $20.4 $5.44 Million - $6.71 Million	-329,051 Reduced 73.79%	116,871 $2.01 Million
Q1 2021 May 13, 2021	BUY	$16.56 - $25.46 $5.68 Million - $8.74 Million	343,091 Added 333.65%	445,922 $8.92 Million
Q4 2020 Jan 19, 2021	SELL	$15.77 - $19.03 $11.5 Million - $13.8 Million	-727,431 Reduced 87.61%	102,831 $1.75 Million
Q3 2020 Nov 16, 2020	SELL	$16.59 - $24.79 $1.09 Million - $1.63 Million	-65,910 Reduced 7.35%	830,262 $13.8 Million
Q2 2020 Jul 17, 2020	SELL	$16.86 - $23.44 $3.88 Million - $5.39 Million	-230,034 Reduced 20.43%	896,172 $20.8 Million
Q1 2020 Apr 16, 2020	BUY	$14.47 - $27.96 $6.65 Million - $12.9 Million	459,806 Added 69.0%	1,126,206 $20.1 Million
Q4 2019 Feb 14, 2020	SELL	$15.87 - $23.12 $2.02 Million - $2.95 Million	-127,506 Reduced 16.06%	666,400 $14.4 Million
Q3 2019 Nov 14, 2019	SELL	$16.91 - $36.27 $1.17 Million - $2.51 Million	-69,223 Reduced 8.02%	793,906 $14.5 Million
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $1.08 Million - $1.26 Million	34,779 Added 4.2%	863,129 $30.7 Million
Q1 2019 May 07, 2019	BUY	$31.58 - $46.35 $1.04 Million - $1.53 Million	32,961 Added 4.14%	828,350 $27.8 Million
Q4 2018 Jan 25, 2019	SELL	$30.43 - $56.65 $15.3 Million - $28.5 Million	-502,897 Reduced 38.74%	795,389 $26.1 Million
Q3 2018 Oct 30, 2018	BUY	$46.46 - $68.49 $9.57 Million - $14.1 Million	205,891 Added 18.85%	1,298,286 $79.1 Million
Q2 2018 Aug 03, 2018	BUY	$46.25 - $104.45 $19.3 Million - $43.5 Million	416,337 Added 61.58%	1,092,395 $53.3 Million
Q1 2018 Apr 30, 2018	BUY	$57.4 - $108.44 $38.8 Million - $73.3 Million	676,058 New	676,058 $71.8 Million

Others Institutions Holding NKTR

# of Institutions

146

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

Deep Track Capital, LP Greenwich, CT

15.9M
Shares

$15.9 Million
0.76% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$15.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$13.1 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

9.4M
Shares

$9.4 Million
0.22% of portfolio
Samlyn Capital, LLC New York, NY

9.2M
Shares

$9.2 Million
0.19% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $187M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.

Account